Trial Profile
A randomized, double-blind, placebo-controlled, parallel group comparative study of HP-3060 in patients with seasonal allergic rhinitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 May 2017
Price :
$35
*
At a glance
- Drugs Emedastine (Primary) ; Levocetirizine
- Indications Allergic rhinitis
- Focus Registrational; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 10 May 2017 Status changed from recruiting to completed.
- 16 Dec 2015 New trial record